FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frank Visser

Research Profile

Chemicals & Drugs

Physiology

Living Beings

Concepts & Ideas

Structure-Activity Relationship

Anatomy

Oocytes

Co-author Network

Publications

TOP 3
Robert J Paproski; Frank Visser; Jing Zhang; Tracey Tackaberry; Vijaya Damaraju; Stephen A Baldwin; James D Young; Carol E Cass
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Frank Visser; Jonathan Lytton
K+ -dependent Na+/Ca2+ exchangers: key contributors to Ca2+ signaling.
Frank Visser; Lijie Sun; Vijaya L Damaraju; Tracey Tackaberry; Yunshan Peng; Morris J Robins; Stephen A Baldwin; James D Young; Carol E Cass
Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding, and catalytic turnover.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frank Visser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Robert J Paproski; Frank Visser; Jing Zhang; Tracey Tackaberry; Vijaya Damaraju; Stephen A Baldwin; James D Young; Carol E Cass
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
The Biochemical journal 2008;414(2):291-300.
2007: Frank Visser; Jonathan Lytton
K+ -dependent Na+/Ca2+ exchangers: key contributors to Ca2+ signaling.
Physiology (Bethesda, Md.) 2007;22():185-92.
2007: Frank Visser; Lijie Sun; Vijaya L Damaraju; Tracey Tackaberry; Yunshan Peng; Morris J Robins; Stephen A Baldwin; James D Young; Carol E Cass
Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding, and catalytic turnover.
The Journal of biological chemistry 2007;282(19):14148-57.
2007: Jing Zhang; Frank Visser; Karen M King; Stephen A Baldwin; James D Young; Carol E Cass
The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.
Cancer metastasis reviews 2007;26(1):85-110.
2007: Frank Visser; Valeria Valsecchi; Lucio Annunziato; Jonathan Lytton
Exchangers NCKX2, NCKX3, and NCKX4: identification of Thr-551 as a key residue in defining the apparent K(+) affinity of NCKX2.
The Journal of biological chemistry 2007;282(7):4453-62.
2006: Ju-Young Lee; Frank Visser; Jae Sung Lee; Kyu-Hee Lee; Jae-Won Soh; Won-Kyung Ho; Jonathan Lytton; Suk-Ho Lee
Protein kinase C-dependent enhancement of activity of rat brain NCKX2 heterologously expressed in HEK293 cells.
The Journal of biological chemistry 2006;281(51):39205-16.
2006: Jing Zhang; Xuejun Sun; Kyla M Smith; Frank Visser; Pat Carpenter; Gerry M Barron; Yunshan Peng; Morris J Robins; Stephen A Baldwin; James D Young; Carol E Cass
Studies of nucleoside transporters using novel autofluorescent nucleoside probes.
Biochemistry 2006;45(4):1087-98.
2005: Jing Zhang; Kyla M Smith; Tracey Tackaberry; Frank Visser; Morris J Robins; Lars P C Nielsen; Ireneusz Nowak; Edward Karpinski; Stephen A Baldwin; James D Young; Carol E Cass
Uridine binding and transportability determinants of human concentrative nucleoside transporters.
Molecular pharmacology 2005;68(3):830-9.
2005: Frank Visser; Jing Zhang; R Taylor Raborn; Stephen A Baldwin; James D Young; Carol E Cass
Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
Molecular pharmacology 2005;67(4):1291-8.
2005: Frank Visser; Stephen A Baldwin; R Elwyn Isaac; James D Young; Carol E Cass
Identification and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters.
The Journal of biological chemistry 2005;280(12):11025-34.
2005: Sambasivarao Damaraju; Jing Zhang; Frank Visser; Tracey Tackaberry; Jennifer Dufour; Kyla M Smith; Melissa D Slugoski; Mabel W L Ritzel; Stephen A Baldwin; James D Young; Carol E Cass
Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene.
Pharmacogenetics and genomics 2005;15(3):173-82.
2005: Vijaya L Damaraju; Frank Visser; Jing Zhang; Delores Mowles; Amy M L Ng; James D Young; Hiremagalur N Jayaram; Carol E Cass
Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside.
Molecular pharmacology 2005;67(1):273-9.
2004: Mark F Vickers; Jing Zhang; Frank Visser; Tracey Tackaberry; Morris J Robins; Lars P C Nielsen; Ireneusz Nowak; Stephen A Baldwin; James D Young; Carol E Cass
Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae.
Nucleosides, nucleotides & nucleic acids 2004;23(1-2):361-73.
2003: Jing Zhang; Frank Visser; Mark F Vickers; Thack Lang; Morris J Robins; Lars P C Nielsen; Ireneusz Nowak; Stephen A Baldwin; James D Young; Carol E Cass
Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae.
Molecular pharmacology 2003;64(6):1512-20.
2002: Frank Visser; Mark F Vickers; Amy M L Ng; Stephen A Baldwin; James D Young; Carol E Cass
Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
The Journal of biological chemistry 2002;277(1):395-401.
2002: Mark F Vickers; Rakesh Kumar; Frank Visser; Jing Zhang; Jahangir Charania; R Taylor Raborn; Stephen A Baldwin; James D Young; Carol E Cass
Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae.
Biochemistry and cell biology = Biochimie et biologie cellulaire 2002;80(5):639-44.